AAPP members have developed tools and toolkits for the benefit of fellow psychiatric pharmacists and to further the knowledge of other pharmacists and health care professionals. You are encouraged to share these to educate others and highlight the value of psychiatric pharmacists. For practice-related resources, explore the Employer Resource Center.
-
Introduction to Psychiatric Pharmacy
- Medication Database
- AIMS Assessment and Tardive Dyskinesia: Toolkit
- Comprehensive Medication Management (CMM): Toolkit
- Rating Scale Resources: Toolkit, Resources
- Research: Toolkit, Core Outcomes
-
Anxiety and Anxiety-Related Disorders: Guidelines
- Benzodiazepine Taper: Toolkit
- Biostatistics and Research Design in Psychiatry
-
Bipolar Disorder: Guidelines, Major Clinical Trials
- Antipsychotics: Medication Monitoring, Dose Equivalents
- LAI Psychotropics: Toolkit
- Antiepileptics / Mood Stabilizers: Medication Monitoring
-
Depression: Guidelines, Major Clinical Trials
- MAOI: Toolkit
- Neurocognitive Disorders: Guidelines
-
Neurodevelopmental, Disruptive, Impulse-Control and Conduct Disorders: Guidelines
- Stimulant Shortages: Toolkit
-
Neurologic Disorders
- Medication-Induced Movement Disorders: Guidelines
- Migraine and Headaches: Guidelines
- Neurodegenerative Disorders: Guidelines
- Neuropathic Pain: Guidelines
- Antiepileptics / Mood Stabilizers: Medication Monitoring
- Seizure Disorders: Guidelines
- Traumatic Brain Injury: Guidelines
-
Personality Disorders and Eating Disorders
- Eating Disorders: Guidelines
- Personality Disorders: Guidelines
- Regulatory Issues in Pharmacy Practice
-
Schizophrenia Spectrum and Other Psychotic Disorders
- General: Guidelines, Major Clinical Trials
- AIMS Assessment and Tardive Dyskinesia: Toolkit
- Antipsychotics: Medication Monitoring, Dose Equivalents
- Clozapine: Toolkit, 2025 Clozapine Product Label-Post REMS
- LAI Psychotropics: Toolkit
- Sleep-Wake Disorders: Guidelines
-
Substance-Related Disorders
- General: Guidelines, Major Clinical Trials
- Alcohol Use Disorder: Toolkit
- Alcohol and Benzodiazepine Withdrawal Management: Toolkit
- Buprenorphine Initiation: Toolkit
- Cannabis Use Disorder: Toolkit
- Harm Reduction: Toolkit
- LAI Psychotropics: Toolkit
- Medication Interactions with Drugs of Abuse
- Methamphetamine Use Disorder: Toolkit
- Opioid Use Disorders: Medication Management: Toolkit
- Pain Management in Patients with Substance Use Disorder(s)
- Urine Drug Screens: Toolkit, Utilization in Clinical Practice
- Xylazine: Toolkit
-
Other
- Agitation and Aggression: Toolkit
- Child and Adolescent Psychiatry
- Clinical Pearls Slides from AAPP Annual Meetings 2024-2025
- CYP Substrate/Inducer/Inhibitor List: Psychotropic-focus
- Hepatitis C: Toolkit
- Psychedelics: Toolkit
- Psychotropic Medication and Hepatic Impairment
- Psychotropic Medication and Renal Impairment
- Psychotropic Medications in Pregnancy
- QTc Prolonging Medications